Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Firms / M••••••••• V••••••• L••

M••••••••• V••••••• L••

Micro VC · probableBoston, MAm•••••••••SEC exempt reporting adviser

venture manager, reported GAV $4.7M across 2 vehicles

Importance
7
low
Active deployment
0
low
Emerging
0
low
Completeness
56
elevated
Freshness
100
high
Research priority
2
low
Identity and regulatory footprint
Headquarters
Boston, MAadviserinfo.sec.gov
Office address
501 BOYLSTON ST., 10TH FLOOR, Boston, MA, 02116adviserinfo.sec.gov
Business phone
617-513-8018adviserinfo.sec.gov
SEC adviser type
exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
unknown
Latest Form ADV
Feb 15, 2024
Private funds reported
1 (1 venture capital funds)adviserinfo.sec.gov
Private fund gross assets
$4.7Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
business email
davidstanton@medscienceventures.commedscienceventures.compublished by the subject
business phone
617-513-8018adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
no observed deals yet
Stated (the firm’s website)
Sectors
biotech
Stages
not stated or not yet read
Geography
not stated
Check size
not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors: no observed deals yet
lead rate n/afollow-on rate n/anew logos, 12 months 0
Funds and vehicles
2 reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
M••••••••• V•••••••• L•••Fund2016 form d first saleHarvest$4.7M
Feb 15, 2024
16$4.6M
of $10.0M
Mar 14, 2019
A••••• V••••••• S•• •••• L•••••SPV or co-invest vehicleunknownUnknownunknownunknown$0Mar 14, 2025
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
7 current, 0 departed
Investments on record
0 edges, 0 companies, 0 partner-attributed
No investment on record yet. Edges arrive from the firm’s portfolio page, financing announcements, and Form D board seats.
Co-investors
0 relationships from shared deals, counted for the whole firm
No co-investor relationship yet: these are derived only from rounds and portfolio listings the graph has seen both investors on.
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
3 dated events
  1. May 1, 2019
    A••• Z•••• joined Schedule A of M••••••••• V••••••• L•• as Member
  2. Aug 31, 2016
    M••••••••• V••••••• L•• first filed Form ADV (ERA, venture capital fund adviser exemption)
  3. Aug 31, 2016
    M••••••••• V•••••••• L••• first reported on Form ADV by M••••••••• V••••••• L•• (Venture Capital Fund), GAV $1,697,934
Classification history
  1. Sep 12, 2026
    Micro VC (probable, 80%, cls-1)
    venture manager, reported GAV $4.7M across 2 vehicles
  2. Sep 12, 2026
    Micro VC (probable, 80%, cls-1)
    venture manager, reported GAV $4.7M across 1 vehicles
Evidence
33 observations from 2 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
SEC adviser typeexempt_reporting_adviserFeb 15, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2016-08-31Feb 15, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Adv history loadedadv-hist-1Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2024-02-15Feb 15, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Venture share of reported funds1Feb 15, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone617-513-8018Feb 15, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Contact page urlhttps://www.medscienceventures.com/contact-us
contact page linked from the home page
Sep 17, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Contact page urlhttps://www.medscienceventures.com/contact-us
contact page linked from the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
HeadquartersBoston, MAFeb 15, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office address501 BOYLSTON ST., 10TH FLOOR, Boston, MA, 02116Feb 15, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Legal formLimited Liability CompanyFeb 15, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private funds reported1Feb 15, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$4.7MFeb 15, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Stated sectorsbiotech
sector words on the home page
Sep 18, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorsbiotech
sector words on the home page
Sep 17, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorsbiotech
sector words on the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorsbiotech
sector words on the home page
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Venture funds reported1Feb 15, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
WebsiteHTTP://WWW.MEDSCIENCEVENTURES.COMFeb 15, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Site titleMedScience Ventures, LLC
title tag
Sep 18, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Site titleMedScience Ventures, LLC
title tag
Sep 17, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Site titleMedScience Ventures, LLC
title tag
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Site titleMedScience Ventures, LLC
title tag
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)